Characterization of CCX282-B, an Orally Bioavailable...

Journal of Pharmacology and Experimental Therapeutics 2010 / 10 Vol. 335; Iss. 1

Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease

Walters, M. J., Wang, Y., Lai, N., Baumgart, T., Zhao, B. N., Dairaghi, D. J., Bekker, P., Ertl, L. S., Penfold, M. E. T., Jaen, J. C., Keshav, S., Wendt, E., Pennell, A., Ungashe, S., Wei, Z., Wright
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
335
Language:
english
Journal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.110.169714
Date:
October, 2010
File:
PDF, 1.31 MB
english, 2010
Conversion to is in progress
Conversion to is failed